CORONA Remedies Limited
WhiteOak Capital Mutual Fund bought 1,45,000 shares of CORONA Remedies Limited for ₹25.09 Cr at ₹1730.00 apiece in a block deal on June 17, 2026.
Corona Remedies Limited, founded in 2004 and headquartered in Ahmedabad, is a pharmaceutical company manufacturing and distributing medicines across women's healthcare, cardiology, pain management, and urology. The company operates two manufacturing facilities in Gujarat and Himachal Pradesh, holds EU-GMP and WHO certifications, and maintains market leadership positions in multiple therapeutic segments including rank #5 in women's healthcare and pain management.
Founded by Prashant Khemka, former CIO of Goldman Sachs Asset Management India. Manages over Rs 20,000 crore with a concentrated bottom-up approach rooted in fundamental quality research. WhiteOak's edge is the proprietary SQGLP (Scalability, Quality, Growth, Longevity, Price) framework applied with global research standards to Indian equities.